Relationship between Serum Interleukin-6 Level and Severity of Acne Vulgaris in Women
DOI:
https://doi.org/10.36408/mhjcm.v13i2.1403Keywords:
Acne Vulgaris, IL-6 Levels, Severity of Acne VulgarisAbstract
BACKGROUND: Acne vulgaris is more common in women than men and is observed more frequently in older adolescents than younger adolescents (pre-teens). This is due to higher sebum production, which supports the growth of Propionibacterium acnes. Propionibacterium acnes contributes to initiating and maintaining inflammatory processes induced by immunological reactions. It activates the Toll-like receptor (TLR) 2 and 4 immune systems by releasing interleukin-6 (IL-6) as a core mediator of inflammation.
AIMS: This study aims to determine the relationship between serum IL-6 levels and the severity of acne vulgaris in women
METHOD: This research employs an analytical observational study design with a cross-sectional approach, involving 15 female subjects diagnosed with acne vulgaris, divided into three groups. The study will occur in Semarang city from July 2024 to September 2024.
RESULT: This study involved 15 female students from Diponegoro University, categorized based on the severity of acne vulgaris (mild, moderate, severe). Blood samples were taken to measure serum IL-6 levels using the ELISA method. The average IL-6 levels found were: mild 1.00 ± 0.55 pg/ml, moderate 1.47 ± 0.27 pg/ml, and severe 1.99 ± 0.42 pg/ml. Analysis revealed a significant relationship between serum IL-6 levels and the severity of acne vulgaris (p = 0.011), supporting the hypothesis of a correlation between the two.
CONCLUSION: There is a significant relationship between serum IL-6 levels and the severity of AV in women. There is a meaningful difference in serum IL-6 levels between the mild and severe AV groups.
Downloads
References
1. Heng AHS, Say YH, Sio YY, Ng YT, Chew FT. Epidemiological Risk Factors Associated with Acne Vulgaris Presentation, Severity, and Scarring in a Singapore Chinese Population: A Cross-Sectional Study. Dermatology [Internet]. 2022;238(2):226–35. Available from: https://karger.com/DRM/article/doi/10.1159/000516232
2. Zaidi Z, Hussain K SS. Disorders of the Sebaceous, Sweat and Aprocine Glands. Springer Int Publ AG, part Springer Nat. 2019;p:191–7.
3. Sibero HT, Sirajudin A, Anggraini D. Prevalensi dan Gambaran Epidemiologi Akne Vulgaris di Provinsi Lampung The Prevalence and Epidemiology of Acne Vulgaris in Lampung. J Farm Komunitas [Internet]. 2019;3(2):62–8. Available from: https://e-journal.unair.ac.id/JFK/article/view/21922
4. Jusuf NK, Putra IB, Puteri Rangkuti AD. Assessing Acne Severity: Teledermatology Versus Face to Face Consultations During the COVID-19 Pandemic. J Clin Aesthet Dermatol [Internet]. 2023 Jan;16(1):30–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/36743968
5. Kutlu Ö, Karadağ AS, Wollina U. Adult acne versus adolescent acne: a narrative review with a focus on epidemiology to treatment. An Bras Dermatol. 2023;98(1):75–83.
6. Vasam M, Korutla S, Bohara RA. Acne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology based advances. Biochem Biophys Reports [Internet]. 2023 Dec;36:101578. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2405580823001590
7. Singh S, Khurana A, Chitkara A. Evaluation of Serum Levels of Interleukins 6, 8, 17 and 22 in Acne Vulgaris: A Cross-Sectional Study. Indian J Dermatol [Internet]. 2023;68(2):233. Available from: http://www.ncbi.nlm.nih.gov/pubmed/37275817
8. Nauli A, Imam PI, Putra B, K SKK, Ii P, Nelva P, et al. Hubungan antara Kadar Interleukin-6 (IL-6) dengan Kadar High Sensitivity C-Reactive Protein ( HS-CRP) Pada Akne Vulgarus. 2023;6.
9. Stańkowska A, Bergler-Czop B, Brzezińska-Wcisło L. Interleukins-6, -8 and -12p40 and C-reactive protein levels in patients with acne vulgaris with various severityof skin changes. Dermatology Rev [Internet]. 2020;107(4):308–22. Available from: https://www.termedia.pl/doi/10.5114/dr.2020.99876
10. Jaber RM, Alnshash BM, Mousa SN, Fayoumi HS, Al-Qaderi LM, Zant AM. The Epidemiology of Acne Vulgaris among Adolescents and Young Adults in Jordan University Hospital. Open J Nurs. 2020;10(04):353–66.
11. Naibaho C. Gambaran Faktor-Faktor Pencetus Timbulnya Akne Vulgaris Pada Mahasiswa/i Fakultas Kedokteran Universitas HKBP Nommensen. J Chem Inf Model. 2020;53(9):1689–99.
12. Afnanita et al. 2023. Faktor-Faktor Yang Mempengaruhi Timbulnya Acne Vulgaris Pada Remaja Remaja Santri Pesantren Babun Najah. J Kesehat Tambusai. 2023;4(3):3144–51.
13. Luqman N, Hassan S, Asghar R, Waheed F, Khalid M, Shaheen JA, et al. Knowledge, attitude and practices about acne vulgaris among acne patients. J Pakistan Assoc Dermatologists. 2021;30(4):592–7.
14. Lajevardi V, Ghodsi SZ, Daneshpazhooh M, Kazemi H, Aryanian Z, Goodarzi A. The relationship between body mass index and the severity of acne. Iran J Dermatology. 2014;17(67):13–7.
15. Elhanboli GM. Role of InterLeukins in acne: a systematic review and meta-analysis Introduction. Print) Fayoum Univ Med J Elhanboli al. 2021;9(1):28–35.
16. Maryanto, E. P. (2020). Hubungan Penggunaan Produk Kosmetik Terhadap Kejadian Akne Vulgaris. Jurnal medika hutama, 2(01 Oktober), 304-307.
17. Merliani, M. (2024). GAMBARAN PENGETAHUAN DAN PERILAKU MAHASISWA TINGKAT TIGA POLITEKNIK KESEHATAN TANJUNGKARANG TENTANG SWAMEDIKASI WAJAH BERJERAWAT(Doctoral dissertation, Poltekkes Kemenkes Tanjungkarang).
18. Witkam, W. C., Dal Belo, S. E., Pourhamidi, S., Raynaud, E., Moreau, M., Aguilar, L., ... & Pardo, L. M. (2024). The epidemiology of acne vulgaris in a multiethnic adolescent population from Rotterdam, the Netherlands: a cross-sectional study. Journal of the American Academy of Dermatology, 90(3), 552-560.
19. Al-falah AA, Subagio, Gading PW. Hubungan Pengetahuan Dengan Tingkat Keparahan Jerawat (Acne Vulgaris) Pada Mahasiswa Program Studi Kedokteran Fakultas Kedokteran Dan Ilmu Kesehatan Universitas Jambi. J Med Stud. 2021;1(2):8–16.
20. Hirano, T. (2021). IL-6 in inflammation, autoimmunity and cancer. International Immunology, 33(3), 127–148. https://doi.org/10.1093/intimm/dxaa078
21. Inoue, D., Ohba, K., & Shibata, T. (2025). UVB-/Age-Dependent Upregulation of Inflammatory Factor Interleukin-6 Receptor (IL-6R) in Keratinocytes Stimulates Melanocyte Dendricity. International Journal of Molecular Sciences, 26(22), 10971.
22. Aletaha, D., Kerschbaumer, A., Kastrati, K., Dejaco, C., Dougados, M., McInnes, I. B., Sattar, N., Stamm, T. A., Takeuchi, T., Trauner, M., van der Heijde, D., Voshaar, M., Winthrop, K. L., Ravelli, A., Betteridge, N., Burmester, G.-R. R., Bijlsma, J. W. J., Bykerk, V., Caporali, R., Choy, E. H., Codreanu, C., Combe, B., Crow, M. K., de Wit, M., Emery, P., Fleischmann, R. M., Gabay, C., Hetland, M. L., Hyrich, K. L., Iagnocco, A., Isaacs, J. D., Kremer, J. M., Mariette, X., Merkel, P. A., Mysler, E. F., Nash, P., Nurmohamed, M. T., Pavelka, K., Poor, G., Rubbert-Roth, A., Schulze-Koops, H., Strangfeld, A., Tanaka, Y., & Smolen, J. S. (2021). Consensus statement on blocking interleukin‑6 receptor and interleukin‑6 in inflammatory conditions: An update. Annals of the Rheumatic Diseases, 82(6), 773–784. https://doi.org/10.1136/ard-2021-219464
23. Khoirunnisa S, Intiyati A, Hatijah N. The Relationship Between Carbohydrate and Saturated Fat Intake with Vulgaris in Grade 3 Female Students at Department of Nutrition Poltekkes Kemenkes Surabaya. J Nutr Explor. 2023;1(1):29–39.
24. Naibaho C. Gambaran Faktor-Faktor Pencetus Timbulnya Akne Vulgaris Pada Mahasiswa/i Fakultas Kedokteran Universitas HKBP Nommensen. J Chem Inf Model. 2020;53(9):1689–99.
25. Sugiyono. (2020). Metode penelitian kuantitatif, kualitatif, dan R&D (24th ed.). Alfabeta.
26. Heng, A. H. S., Say, Y. H., Sio, Y. Y., Ng, Y. T., & Chew, F. T. (2021). Gene variants associated with acne vulgaris presentation and severity: a systematic review and meta-analysis. BMC medical genomics, 14(1), 103.
27. Ragab, M., Hassan, E. M., Elneily, D., & Fathallah, N. (2021). Association of interleukin‐6 gene promoter polymorphism with acne vulgaris and its severity. Clinical and experimental dermatology, 44(6), 637-642.
28. Triatmakusuma, Y., Praharsini, I. G. A. A., Darmaputra, I. G. N., Winaya, K. K., Karna, N. L. P. R. V., & Puspawati, N. M. D. (2024). Serum interleukin-6 levels are positively correlated with the severity of acne vulgaris. Journal La Medihealtico, 5(1), 158-166.
29. Jin, Z., Song, Y., & He, L. (2023). A review of skin immune processes in acne. Frontiers in immunology, 14, 1324930.
30. Knight, V., & Sepiashvili, L. (2025). Cytokine testing and challenges for diagnostic and clinical monitoring use. Journal of Allergy and Clinical Immunology, 155(2), 410-413.
31. Heng, A. H. S., Say, Y. H., Sio, Y. Y., Ng, Y. T., & Chew, F. T. (2021). Gene variants associated with acne vulgaris presentation and severity: a systematic review and meta-analysis. BMC medical genomics, 14(1), 103.
32. Mderm, R. Y. M. M., & Baruch Kaplan, M. D. Acne Vulgaris: Advances in Pathogenesis and Innovations in Therapeutic Strategies. development, 5, 6.
33. Alwarawrah, Y., Nichols, A. G., Patel, I., Ball, A. B., & MacIver, N. J. (2025). Targeting IL-6 receptor mediated metabolic pathways to control Th17 cell differentiation and inflammatory responses. Frontiers in Immunology, 16, 1568514.
34. de Magalhães Alves, N. R., Kurizky, P. S., da Mota, L. M. H., de Albuquerque, C. P., Esper, J. T., Campos, A. S. C., ... & Gomes, C. M. (2024). Elevated serum IL-6 levels predict treatment interruption in patients with moderate to severe psoriasis: a 6-year real-world cohort study. Anais Brasileiros de Dermatologia, 99(1), 34-42.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Najwa Luna Falika, Amallia Nuggetsiana Setyawati, Novi Kusumaningrum, Galih Sari Damayanti (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
